FDA 483 - B & J Group - October 02, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspected B & J Group in Morrisville, PA, a manufacturer of OTC veterinary drug products, from September 26 to October 2, 2023. The inspection revealed six significant deficiencies, including a lack of a stability testing program, inadequate component identification, uncalibrated laboratory instruments, and poor record-keeping for retain samples, cleaning logs, and batch production. Several of these issues were noted as repeat observations, indicating persistent non-compliance.
ID · c8619f2b-9754-4dba-b573-305ff5a31c51